$NUKK
Nukkleus Inc. Stock $nukk

$nukk Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023019202 Filed on March 10, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$5.486M	$5.431M	$22.17M
YoY Change	1.31%	-5.25%	14.48%
Gross Profit	$148.0K	-$54.87K	-$661.4K
YoY Change	-145.36%	-90.91%	703.35%
Gross Profit Margin
Selling, General & Admin	$888.0K	$1.015M
YoY Change	-39.23%	-20.36%
% of Gross Profit	600.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.186M	$592.9K	$264.2K
YoY Change	-21.2%	-34.99%	-43.7%
% of Gross Profit	801.42%
Operating Expenses	$78.38K	$107.7K	$1.202M
YoY Change	-83.3%	-73.78%	79.22%
Operating Profit	-$78.38K	-$162.5K	-$1.202M
YoY Change	-83.3%	-83.97%	79.22%
Interest Expense	-$930.00	$214.6K	$234.8K
YoY Change	-110.34%	-1066.85%	227.05%
% of Operating Profit
Other Income/Expense, Net	-$925.00	$2.570K	$234.8K
YoY Change	-110.29%	-310.66%	227.05%
Pretax Income	-$79.31K	$107.0K	-$967.6K
YoY Change	-82.77%	-124.72%	61.5%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$79.31K	$107.0K	-$967.6K
YoY Change	-82.77%	-124.72%	61.5%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.04	-$0.11	-$0.21
Diluted Earnings Per Share	-$0.04	$0.02	-$0.21
COMMON SHARES
Basic Shares Outstanding	1.817M shares	2.076M shares	4.636M shares
Diluted Shares Outstanding	1.949M shares	10.07M shares	4.636M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.464M	$6.111M	$6.111M
YoY Change	-89.28%	-87.18%	-87.18%
Cash & Equivalents	$4.464M	$6.111M
Short-Term Investments			$0.00
Other Short-Term Assets	$740.00	$740.00	$740.00
YoY Change	-99.52%	-99.97%	-99.98%
Inventory
Prepaid Expenses
Receivables	$189.2K	$102.8K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.464M	$6.112M	$6.112M
YoY Change	-89.32%	-87.18%	-87.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.602M	$6.602M
YoY Change	-42.75%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$4.464M	$6.112M	$6.112M
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$4.464M	$6.112M	$6.112M
YoY Change	-89.32%	-87.18%	-87.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$286.2K	$315.0K	$315.0K
YoY Change	22.28%	1.75%	1.75%
Accrued Expenses	$579.7K	$424.9K
YoY Change	28.41%
Deferred Revenue
YoY Change
Short-Term Debt	$3.817M	$3.651M	$3.651M
YoY Change	34.88%	124.62%	124.62%
Long-Term Debt Due	$17.50K
YoY Change
Total Short-Term Liabilities	$4.103M	$3.966M	$3.966M
YoY Change	33.92%	104.96%	104.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$11.57K	$10.64K	$10.64K
YoY Change	-93.41%	-94.1%	-94.1%
Total Long-Term Liabilities	$11.57K	$10.64K	$10.64K
YoY Change	-93.41%	-94.1%	-94.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.103M	$3.966M	$3.966M
Total Long-Term Liabilities	$11.57K	$10.64K	$10.64K
Total Liabilities	$4.115M	$3.976M	$3.976M
YoY Change	27.02%	87.98%	87.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.966M	-$7.800M
YoY Change		36.55%
Common Stock	$3.880M	$3.880M
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.086M	-$3.920M	$2.135M
YoY Change
Total Liabilities & Shareholders Equity	$4.464M	$6.112M	$6.112M
YoY Change	-89.32%	-87.18%	-87.18%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$79.31K	$107.0K	-$967.6K
YoY Change	-82.77%	-124.72%	61.5%
Depreciation, Depletion And Amortization	$1.186M	$592.9K	$264.2K
YoY Change	-21.2%	-34.99%	-43.7%
Cash From Operating Activities	-$107.2K	-$78.25K	-$1.133M
YoY Change	-84.67%	-64.82%	162.88%
INVESTING ACTIVITIES
Capital Expenditures	$41.25K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$47.39M
YoY Change	-100.0%	-100.0%	-3533.89%
Cash From Investing Activities	$0.00	$0.00	$47.39M
YoY Change	-100.0%	-100.0%	-3533.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.540M	-25.01M	-$40.43M
YoY Change	-71.08%	-1910.57%	-3026.35%
NET CHANGE
Cash From Operating Activities	-$107.2K	-78.25K	-$1.133M
Cash From Investing Activities	0.000	0.000	$47.39M
Cash From Financing Activities	-$1.540M	-25.01M	-$40.43M
Net Change In Cash	-$1.647M	-25.09M	$5.827M
YoY Change	1175.39%	11256.1%	-1457.07%
FREE CASH FLOW
Cash From Operating Activities	-$107.2K	-$78.25K	-$1.133M
Capital Expenditures	$41.25K
Free Cash Flow	-$148.4K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39341
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Floor 20-21
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 55 Loushanguan Road
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Changning District
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Shanghai
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022	dei	City Area Code CityAreaCode	(86)
CY2022	dei	Local Phone Number LocalPhoneNumber	021-80125497
CY2022	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value per share
CY2022	dei	Trading Symbol TradingSymbol	BRLI
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	42573198	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1816733	shares
CY2022	dei	Auditor Firm AuditorFirmId	5395
CY2022	dei	Auditor Name AuditorName	Marcum Asia CPAs LLP
CY2022	dei	Auditor Location AuditorLocation	New York
CY2022Q4	us-gaap	Cash Cash	6110807	usd
CY2021Q4	us-gaap	Cash Cash	283403	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	738	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	47387687	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6111545	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	47671090	usd
CY2022Q4	us-gaap	Assets Assets	6111545	usd
CY2021Q4	us-gaap	Assets Assets	47671090	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	315023	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	309597	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	970600	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	500	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	2680227	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1624833	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3965850	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1934930	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	10643	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	180479	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3976493	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2115409	usd
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	564936	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4600000	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	6055016	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	47387687	usd
CY2021Q4	brli	Preferred Stock Shares Authorized Unlimited Shares PreferredStockSharesAuthorizedUnlimitedShares	unlimited
CY2022Q4	brli	Preferred Stock Shares Authorized Unlimited Shares PreferredStockSharesAuthorizedUnlimitedShares	unlimited
CY2021Q4	brli	Common Stock Shares Authorized Unlimited Share CommonStockSharesAuthorizedUnlimitedShare	unlimited
CY2022Q4	brli	Common Stock Shares Authorized Unlimited Share CommonStockSharesAuthorizedUnlimitedShare	unlimited
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1511000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1511000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1511000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1511000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3880288	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3880288	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7800252	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5712294	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3919964	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1832006	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6111545	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47671090	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1202399	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	670916	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1202399	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-670916	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-169836	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67155	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	64949	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	4634	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	234785	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	71789	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-967614	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-599127	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4636222	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6111000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	154808	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-599127	usd
CY2021	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-1380000	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-7687	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1832006	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-967614	usd
CY2022	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-1055394	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-64950	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3919964	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-967614	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-599127	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-169836	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67155	usd
CY2021	brli	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount	4634	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	737	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14600	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5426	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	225402	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1132761	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-430914	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1380000	usd
CY2022	brli	Proceeds From Sale Of Investment Of Cash In Trust Account ProceedsFromSaleOfInvestmentOfCashInTrustAccount	47387687	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	47387687	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1380000	usd
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	970100	usd
CY2021	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	500	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1055394	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	1381000	usd
CY2022	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	42453015	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40427521	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1381500	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5827404	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	429414	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	283403	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	712817	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6110807	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	283403	usd
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P180D
CY2022	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	2069154	usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1610000	usd
CY2022	brli	Other Offering Cost OtherOfferingCost	459154	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	55789	usd
CY2022Q4	brli	Fair Market Value Percentage FairMarketValuePercentage	0.80	pure
CY2022	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	159203	shares
CY2022	brli	Aggregate Amounts AggregateAmounts	1706347	usd
CY2022	brli	Aggregate Price Per Shares AggregatePricePerShares	10.72
CY2023Q1	brli	Share Issued Price Per Share ShareIssuedPricePerShare	0.08
CY2022	brli	Redeemption Percent RedeemptionPercent	1	pure
CY2022	us-gaap	Other Expenses OtherExpenses	50000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	55789	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	1229096	usd
CY2022	brli	Description Of Trust Account DescriptionOfTrustAccount	which is before March 23, 2023 (or April 23, 2023 if further extended by placing $32,500 into the Trust Account).
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022	brli	Cash And Noncash Equivalents CashAndNoncashEquivalents	55789	usd
CY2021	brli	Cash And Noncash Equivalents CashAndNoncashEquivalents	283403	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	47387687	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	633792	shares
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	1025281	shares
CY2022Q4	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	2375991	shares
CY2021	brli	Subject To Possible Redemption SubjectToPossibleRedemption	4600000	shares
CY2022	brli	Common Stock Per Share CommonStockPerShare	10
CY2020Q4	brli	Ordinary Shares Subject To Possible Redemption1 OrdinarySharesSubjectToPossibleRedemption1	46000000	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	7687	usd
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	1380000	usd
CY2021Q4	brli	Ordinary Shares Subject To Possible Redemption1 OrdinarySharesSubjectToPossibleRedemption1	47387687	usd
CY2022	brli	Redemption Of Share RedemptionOfShare	633792	shares
CY2022	brli	Less Redemption Of Shares LessRedemptionOfShares	6529259	shares
CY2022	brli	Redemption Of Share1 RedemptionOfShare1	1025281	shares
CY2022	brli	Less Redemption Of Shares1 LessRedemptionOfShares1	10742905	shares
CY2022	brli	Redemption Of Shares2 RedemptionOfShares2	2375991	shares
CY2022	brli	Less Redemption Of Shares2 LessRedemptionOfShares2	-25180851	shares
CY2022	brli	Add Accretion Of Carrying Value To Redemption Value AddAccretionOfCarryingValueToRedemptionValue	64950	shares
CY2022	brli	Reclassifications Of Temporary To Permanent Equity1 ReclassificationsOfTemporaryToPermanentEquity1	1055394	shares
CY2022Q4	brli	Ordinary Shares Subject To Possible Redemption1 OrdinarySharesSubjectToPossibleRedemption1	6055016	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-967614	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-599127	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4636222	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6111000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2022	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	The initial shareholders have agreed not to transfer, assign or sell any of the Founder Shares (except to certain permitted transferees) until, with respect to 50% of the Founder Shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, with respect to the remaining 50% of the Founder Shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.
CY2022	brli	Public Per Share Outstanding PublicPerShareOutstanding	0.04
CY2022	brli	Business Acquisition Description Of Trust Account BusinessAcquisitionDescriptionOfTrustAccount	On September 21, 2021, the Company issued an unsecured promissory note to our sponsor (the “Promissory Note III”), pursuant to which we could borrow up to an aggregate principal amount of $461,000, of which $461,000 was outstanding under the Promissory Note III as of December 31, 2022.
CY2022	brli	Working Capital WorkingCapital	970600	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	970100	usd
CY2022	brli	Registration Rights Description RegistrationRightsDescription	Notwithstanding the foregoing, EarlyBirdCapital, Inc. (“EarlyBirdCapital”) may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
CY2022Q4	brli	Cash Fee Equal Percentage CashFeeEqualPercentage	0.01	pure
CY2020Q2	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1511000	shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	564936	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	4600000	shares
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.01
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	261000	shares
CY2022	us-gaap	Increase Decrease In Fair Value Of Price Risk Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1	169836	usd
CY2021	us-gaap	Increase Decrease In Fair Value Of Price Risk Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfPriceRiskFairValueHedgingInstruments1	67155	usd
CY2022	brli	Volatility Volatility	0.034	pure
CY2021	brli	Volatility Volatility	0.105	pure
CY2022Q4	us-gaap	Share Price SharePrice	10.72
CY2021Q4	us-gaap	Share Price SharePrice	10.2
CY2022	brli	Expected Life Of The Warrants To Converts ExpectedLifeOfTheWarrantsToConverts	P5Y2M23D
CY2021	brli	Expected Life Of The Warrants To Converts ExpectedLifeOfTheWarrantsToConverts	P5Y6M21D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0404	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	247634	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-67155	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	180479	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	180479	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-169836	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	10643	usd
CY2022	brli	Aggregate Amount Shares AggregateAmountShares	159203	shares
CY2022	brli	Aggregate Amount Per Shares AggregateAmountPerShares	10.72
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6111000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2022	brli	Interest Earned On Marketable Securities Held In Trust Account InterestEarnedOnMarketableSecuritiesHeldInTrustAccount		usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2021	brli	Proceeds From Sale Of Investment Of Cash In Trust Account ProceedsFromSaleOfInvestmentOfCashInTrustAccount		usd
CY2021	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6111000	shares
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001787518

Files In Submission

Name	View Source	Status
0001213900-23-019202-index-headers.html	Edgar Link	pending
0001213900-23-019202-index.html	Edgar Link	pending
0001213900-23-019202.txt	Edgar Link	pending
0001213900-23-019202-xbrl.zip	Edgar Link	pending
brli-20221231.xsd	Edgar Link	pending
f10k2022ex31-1_brilliant.htm	Edgar Link	pending
f10k2022ex31-2_brilliant.htm	Edgar Link	pending
f10k2022ex32_brilliant.htm	Edgar Link	pending
f10k2022_brilliantacq.htm	Edgar Link	pending
brli-20221231_cal.xml	Edgar Link	unprocessable
brli-20221231_def.xml	Edgar Link	unprocessable
brli-20221231_lab.xml	Edgar Link	unprocessable
brli-20221231_pre.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_brilliantacq_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NUKK
Nukkleus Inc. Stock $nukk

2023 Q1 Form 10-K Financial Statement

#000121390023019202 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUKK Nukkleus Inc. Stock $nukk

2023 Q1 Form 10-K Financial Statement

#000121390023019202 Filed on March 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NUKK
Nukkleus Inc. Stock $nukk